About Brent R Carr
Brent Carr, MD, is a native of Louisiana. Before arriving at the University of Florida, Dr. Carr served as a faculty member at Tulane University in New Orleans for 20 years. He obtained his bachelor’s degree in zoology, physiology and philosophy from Louisiana State University in 1992. He also received his medical degree from LSU in 1996. He then completed an internship and residency at Tulane University. Dr. Carr completed a fellowship in electroconvulsive therapy at Emory University and another fellowship in transcranial magnetic stimulation at Duke University. He is the Chief of ECT services at UF, the department’s psychiatric deep brain stimulation programmer, and has joint faculty appointment in the department of anesthesiology.
At Tulane, Dr. Carr was the director of ECT, and other areas of expertise included college/campus health, attention deficit hyperactivity disorder, anxiety disorders and affective disturbances. Dr. Carr also served at the Veteran’s Hospital in New Orleans, where he treated people with post-traumatic stress disorder and directed the affective disorders/bipolar disorder clinic.
Dr. Carr enjoys teaching, mentoring medical students and training residents and is an advocate for arts and humanities in medicine, rapport building, ethics, compassionate and empathic care and team building within clinical practice. He has a specific interest in neuromodulation and interventional psychiatry and its effectiveness for those with refractory psychiatric illnesses.
PsychiatryAmerican Board of Psychiatry and Neurology
- Attention deficit hyperactivity disorder
- Bipolar disorder
- Deep brain stimulation
- Electroconvulsive therapy
- Generalized anxiety disorder
- Obsessive-compulsive disorder
- Obsessive-compulsive personality disorder
- Post-traumatic stress disorder
- Transcranial Magnetic Stimulation (TMS)
Research in the use of interventional tools for treatment resistant psychiatric illnesses, including electroconvulsive therapy, deep brain stimulation in OCD, ketamine infusion therapy, transcranial magnetic stimulation, direct cortical stimulation and novel psychopharmacotherapeutics.